GHRH


Also found in: Acronyms.

GHRH

, GH-RH

GHRH

 Growth hormone regulatory hormone
References in periodicals archive ?
Stephen Collins, President and CEO of Biscayne Pharmaceuticals, noted, "Biscayne's GHRH agonists have demonstrated encouraging preclinical potential in a number of diseases, including cardiovascular disease and diabetes.
In patients whose pituitary gland is intact, a potential alternative to GH would be the hypothalamic hormone GHRH.
GH responses to GHRP and to GHRH in GH deficient children.
3] Nonstandard abbreviations: GHD, growth hormone deficiency; GH, growth hormone; PD, pyridostigmine; GHRH, growth-hormone-releasing hormone; and GHBP, growth-hormone-binding protein.
Schally, a renowned drug researcher and Nobel laureate, discovered that cancer cells also make GHRH and have receptors for GHRH, thereby fueling their own growth.
announced today that data demonstrating the effectiveness of its plasmid-based growth hormone releasing hormone (pGHRH) technology was recently published in the peer-reviewed journal Molecular Therapy in a paper entitled, "A Comparison of the Growth Responses Following Intramuscular GHRH Plasmid Administration Versus Daily Growth Hormone Injections in Young Pigs.
In healthy individuals, GHRH is made in the brain and directs the pituitary to release the growth hormone needed to manage normal growth and tissue repair.
Much of the earlier work on GHRH and cancer has been conducted in preclinical models.
VGXAH) and its parent company, VGX Pharmaceuticals (VGXP), announced today the execution of an exclusive Distribution and Marketing Agreement for its LifeTide[TM] SW 5 GHRH gene therapy product for pigs in Australia with Country Vet Wholesaling Pty Ltd (CVW).
Inovio will receive milestone payments and royalties on product sales and retains the human applications of its GHRH technology.
The GHRH (growth hormone releasing hormone) gene takes part in growth metabolism according to interaction with various interdependent genes, such as GH (growth hormone), IGF1 (insulin-like growth factor 1), PIT1 (pituitary-specific transcription factor 1), GHRHR (growth hormone releasing hormone receptor) and GHR (growth hormone receptor) (Cogan and Phillips, 1998: Xia et al.
Relative to GH injections, GHRH therapy produces a more physiological response, thereby minimizing safety and tolerability issues associated with chronic, excess GH replacement.